<DOC>
	<DOCNO>NCT02880527</DOCNO>
	<brief_summary>Polymyositis dermatomyositis characterize association myopathic syndrome , inflammatory infiltrates skeletal muscle . They remain , even today , important factor morbidity mortality patient . At present , study evaluate prevalence polymyositis / dermatomyositis ; mainly record United States Japan , prevalence polymyositis / dermatomyositis estimate 3.5 21.5 case / 100 000 ( accord old diagnostic criterion Bohan Peter ) . However , previous work old retrospective ; , almost always perform ( 90 % case ) case report hospital , lead selection bias underestimate true prevalence polymyositis / dermatomyositis general population . Thus , data lead achieve epidemiological study , descriptive , multicenter , base population Normandy .</brief_summary>
	<brief_title>Study Prevalence Polymyositis Dermatomyositis Normandy</brief_title>
	<detailed_description />
	<mesh_term>Dermatomyositis</mesh_term>
	<mesh_term>Polymyositis</mesh_term>
	<criteria>patient polymyositis / dermatomyositis , meet diagnostic criterion ENMC ; patient living Normandy ; patient inform give verbal agreement ; patient myositis diagnose inclusion ( include pathophysiology , clinical phenotype therapeutic care different polymyositis / dermatomyositis )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>